These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 8786544

  • 1. Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
    Ocaña M, Barrios M, Baeyens JM.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1136-42. PubMed ID: 8786544
    [Abstract] [Full Text] [Related]

  • 2. Inhibitors of serine/threonine protein phosphatases antagonize the antinociception induced by agonists of alpha 2 adrenoceptors and GABAB but not kappa-opioid receptors in the tail flick test in mice.
    Moncada A, Cendán CM, Baeyens JM, Del Pozo E.
    Pain; 2005 Mar; 114(1-2):212-20. PubMed ID: 15733647
    [Abstract] [Full Text] [Related]

  • 3. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
    Tseng LF, Collins KA.
    J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of K+ channel blockers on antinociception induced by alpha 2-adrenoceptor, GABAB and kappa-opioid receptor agonists.
    Ocaña M, Baeyens JM.
    Br J Pharmacol; 1993 Nov; 110(3):1049-54. PubMed ID: 7905339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
    Lohmann AB, Welch SP.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):119-27. PubMed ID: 10607867
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological study of 14 beta-(thioglycolamido)-7,8-dihydro-N(cyclopropylmethyl)-normor phinone (N-CPM-TAMO).
    Jiang Q, Seyed-Mozaffari A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1993 Mar 03; 264(3):1021-7. PubMed ID: 7680715
    [Abstract] [Full Text] [Related]

  • 10. dextro- and levo-morphine attenuate opioid delta and kappa receptor agonist produced analgesia in mu-opioid receptor knockout mice.
    Wu HE, Sun HS, Terashivili M, Schwasinger E, Sora I, Hall FS, Uhl GR, Tseng LF.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):103-7. PubMed ID: 16445907
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin test.
    Chung KM, Kim YH, Song DK, Huh SO, Suh HW.
    Neuropeptides; 1999 Dec 15; 33(6):534-41. PubMed ID: 10657537
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M, Ito K, Maeda M, Akahori K, Takahashi S, Jin XL, Matsuda M, Suzuki T, Oka T, Kobayashi H, Hashimoto A.
    Eur J Pharmacol; 2007 Jun 22; 565(1-3):89-97. PubMed ID: 17383634
    [Abstract] [Full Text] [Related]

  • 17. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK, Meert TF.
    J Pharmacol Exp Ther; 2002 Sep 22; 302(3):1253-64. PubMed ID: 12183687
    [Abstract] [Full Text] [Related]

  • 18. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP, Hill KP, Jiang Q, Sebastian A, Archer S, Bidlack JM.
    J Pharmacol Exp Ther; 1999 Apr 22; 289(1):304-11. PubMed ID: 10087018
    [Abstract] [Full Text] [Related]

  • 19. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
    Cichewicz DL, Martin ZL, Smith FL, Welch SP.
    J Pharmacol Exp Ther; 1999 May 22; 289(2):859-67. PubMed ID: 10215664
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.